This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Review

. 2002 Dec;61(6):698-700.

doi: 10.1007/s00393-002-0452-0.

[Recommendations of the Deutschen Gesellschaft für Rheumatologie on therapy of rheumatoid arthritis with the interleukin-1-receptor-antagonist Akakinra (KINERET)]

[Article in German]

B Manger¹; Kommission Pharmakotherapie, Deutschen Gesellschaft für Rheumatologie

Affiliations

PMID: 12491134
DOI: 10.1007/s00393-002-0452-0

Review

[Recommendations of the Deutschen Gesellschaft für Rheumatologie on therapy of rheumatoid arthritis with the interleukin-1-receptor-antagonist Akakinra (KINERET)]

[Article in German]

B Manger et al. Z Rheumatol. 2002 Dec.

. 2002 Dec;61(6):698-700.

doi: 10.1007/s00393-002-0452-0.

Authors

B Manger¹; Kommission Pharmakotherapie, Deutschen Gesellschaft für Rheumatologie

Affiliation

¹ Medizinische Klinik II, Krankenhausstr. 12, 91054 Erlangen.

PMID: 12491134
DOI: 10.1007/s00393-002-0452-0

No abstract available

PubMed Disclaimer

Similar articles

[Anakinra in the treatment of rheumatoid arthritis].
Loft AG, Tarp U, Thomsen BS. Loft AG, et al. Ugeskr Laeger. 2003 Sep 22;165(39):3720-4. Ugeskr Laeger. 2003. PMID: 14558384 Swedish. No abstract available.
[Anakinra for therapy of rheumatoid arthritis].
Tomoo T, Sumida T. Tomoo T, et al. Nihon Rinsho. 2005 Jan;63 Suppl 1:534-7. Nihon Rinsho. 2005. PMID: 15799413 Review. Japanese. No abstract available.
Anakinra, a recombinant human interleukin-1 receptor antagonist (r-metHuIL-1ra), in patients with rheumatoid arthritis: A large, international, multicenter, placebo-controlled trial.
Fleischmann RM, Schechtman J, Bennett R, Handel ML, Burmester GR, Tesser J, Modafferi D, Poulakos J, Sun G. Fleischmann RM, et al. Arthritis Rheum. 2003 Apr;48(4):927-34. doi: 10.1002/art.10870. Arthritis Rheum. 2003. PMID: 12687534 Clinical Trial.
Addressing the safety of anakinra in patients with rheumatoid arthritis.
Fleischmann RM. Fleischmann RM. Rheumatology (Oxford). 2003 May;42 Suppl 2:ii29-35. doi: 10.1093/rheumatology/keg330. Rheumatology (Oxford). 2003. PMID: 12817093 Review.
[Interleukin-1 receptor antagonists in the treatment rheumatoid arthritis].
Zoń-Giebel A, Kotulska A, Giebel S, Cader SA, Kucharz EJ. Zoń-Giebel A, et al. Przegl Lek. 2002;59(11):916-8. Przegl Lek. 2002. PMID: 12715722 Review. Polish.

See all similar articles

Cited by

[Recommendations on therapy using interleukin-1beta-blocking agents].
Manger B, Gaubitz M, Michels H; Kommission Pharmakotherapie der DGRh; German Society of Rheumatology. Manger B, et al. Z Rheumatol. 2009 Nov;68(9):766-71. doi: 10.1007/s00393-009-0542-3. Z Rheumatol. 2009. PMID: 19756659 German.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Springer
Medical
- MedlinePlus Health Information